Authors:
DEGRAMONT A
LOUVET C
ANDRE T
TOURNIGAND C
KRULIK M
Citation: A. Degramont et al., A REVIEW OF GERCOD TRIALS OF BIMONTHLY LEUCOVORIN PLUS 5-FLUOROURACIL48-H CONTINUOUS-INFUSION IN ADVANCED COLORECTAL-CANCER - EVOLUTION OFA REGIMEN, European journal of cancer, 34(5), 1998, pp. 619-626
Authors:
MAINDRAULTGOEBEL F
DEGRAMONT A
LOUVET C
ANDRE T
CAROLA E
GILLESAMAR V
IZRAEL V
KRULIK M
Citation: F. Maindraultgoebel et al., OXALIPLATIN WITH HIGH-DOSE LEUCOVORIN (LV) AND 5-FLUOROURACIL (5FU) 48-HOUR INFUSION IN PRETREATED METASTATIC COLORECTAL-CANCER (FOLFOX6), Annals of oncology, 9, 1998, pp. 173-173
Authors:
TOURNIGAND C
DEGRAMONT A
LOUVET C
ANDRE T
CAROLA E
GILLESAMAR V
MAINDRAULTGOEBEL F
LOTZ JP
MOLITOR JL
Citation: C. Tournigand et al., A SIMPLIFIED BI-MONTHLY REGIMEN WITH LEUCOVORIN (LV) AND 5-FLUOROURACIL (5FU) FOR METASTATIC COLORECTAL-CANCER (MCRC), Annals of oncology, 9, 1998, pp. 189-189
Authors:
ANDRE T
DEGRAMONT A
LOUVET C
CAROLA E
MAINDRAULTGOEBEL F
COUTEAU C
KRULIK M
IZRAEL V
Citation: T. Andre et al., CPT11 WITH HIGH-DOSE LEUCOVORIN (LV) AND 5-FLUOROURACIL (5FU) 48-HOURINFUSION IN PRETREATED METASTATIC COLORECTAL-CANCER (FOLFIRI), Annals of oncology, 9, 1998, pp. 199-199
Authors:
MOLITOR JL
DEGRAMONT A
LOUVET C
DEMUYNCK B
PIGNE A
SEZEUR A
CADY J
LAGADEC B
MILLIEZ J
KRULIK M
Citation: Jl. Molitor et al., LONG-TERM SURVIVAL AFTER CONSOLIDATION INTRAPERITONEAL (IP) CHEMOTHERAPY (CT) IN PATIENTS (PTS) WITH ADVANCED OVARIAN-CARCINOMA (AOC) IN PATHOLOGICAL COMPLETE REMISSION (PCR), Annals of oncology, 9, 1998, pp. 318-318
Citation: H. Bleiberg et A. Degramont, OXALIPLATIN PLUS 5-FLUOROURACIL - CLINICAL-EXPERIENCE IN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Seminars in oncology, 25(2), 1998, pp. 32-39
Authors:
MINEUR P
MENARD JF
LELOET X
BERNARD JF
GROSBOIS B
POLLET JP
AZAIS I
LAPORTE JP
DOYEN C
DEGRAMONT A
WETTERWALD M
EULLERZIEGLER L
PENY AM
MONCONDUIT M
MICHAUX JL
Citation: P. Mineur et al., VAD OR VMBCP IN MULTIPLE-MYELOMA REFRACTORY TO OR RELAPSING AFTER CYCLOPHOSPHAMIDE-PREDNISONE THERAPY (PROTOCOL MY-85), British Journal of Haematology, 103(2), 1998, pp. 512-517
Authors:
SEYMOUR MT
CASSIDY J
WILSON C
PAPAMICHAEL D
HOMERIN M
FIGER A
DEGRAMONT A
Citation: Mt. Seymour et al., OXALIPLATIN, 5-FLUOROURACIL (FU) AND FOLINIC ACID (FA) FIRST-LINE COMBINATION THERAPY IN COLORECTAL-CANCER - RESULTS OF A PHASE-III TRIAL, British Journal of Cancer, 78, 1998, pp. 62-62
Authors:
FRIEDLANDER M
DEGRAMONT A
MILLWARD MJ
BELL D
BUGAT R
HARNETT P
MORENO JA
CAMPBELL L
RIPOCHE V
KAYITALIRE L
Citation: M. Friedlander et al., ACTIVITY OF GEMCITABINE IN STAGE-3 OR STAGE-4 OVARIAN-CANCER - PATIENTS PREVIOUSLY TREATED WITH CISPLATIN (CP)-CONTAINING REGIMENS, European journal of cancer, 33, 1997, pp. 538-538
Authors:
ANDRE T
BENSMAINE MA
LOUVET C
LUCAS V
BEERBLOCK K
DESSEIGNE F
FRANCOIS E
MERROUCHE Y
BOUCHE O
MORVAN F
CAROLA E
DEGRAMONT A
Citation: T. Andre et al., ADDITION OF OXALIPLATIN (ELOXATINE(R), LOHP) TO THE SAME LEUCOVORIN (LV) AND 5-FLUOROURACIL (5FU) BIMONTHLY REGIMENS AFTER PROGRESSION IN PATIENTS (PTS) WITH METASTATIC COLORECTAL-CANCER (MCRC) - PRELIMINARY-REPORT, European journal of cancer, 33, 1997, pp. 738-738
Authors:
RAYMOND E
DEGRAMONT A
LOUVET C
TOURNIGAND C
DEMUYNCK B
BEERBLOCK K
CAROLA E
KRULIK M
Citation: E. Raymond et al., CLINICAL BENEFIT WITH CISPLATIN, HYDROXYUREA AND 5-FLUOROURACIL LEUCOVORIN IN ADVANCED PANCREATIC ADENOCARCINOMA/, European journal of cancer, 33(4), 1997, pp. 696-697
Authors:
DEGRAMONT A
VIGNOUD J
TOURNIGAND C
LOUVET C
ANDRE T
VARETTE C
RAYMOND E
MOREAU S
LEBAIL N
KRULIK M
Citation: A. Degramont et al., OXALIPLATIN WITH HIGH-DOSE LEUCOVORIN AND 5-FLUOROURACIL 48-HOUR CONTINUOUS-INFUSION IN PRETREATED METASTATIC COLORECTAL-CANCER, European journal of cancer, 33(2), 1997, pp. 214-219
Authors:
DEGRAMONT A
BASSET JF
MILAN C
ROUGIER P
BOUCHE O
ETIENNE PL
MORVAN F
LOUVET C
GUILLOT C
FRANCOIS E
BEDENNE L
Citation: A. Degramont et al., RANDOMIZED TRIAL COMPARING MONTHLY LOW-DOSE LEUCOVORIN AND FLUOROURACIL BOLUS WITH BIMONTHLY HIGH-DOSE LEUCOVORIN AND FLUOROURACIL BOLUS PLUS CONTINUOUS-INFUSION FOR ADVANCED COLORECTAL-CANCER - A FRENCH INTERGROUP STUDY, Journal of clinical oncology, 15(2), 1997, pp. 808-815
Authors:
RAYMOND E
DROLET Y
MARPEAU L
LOUVET C
CADY J
TESSIER C
FAIVRE S
OUELLET P
LAVOIE A
RIOUX E
DEGRAMONT A
KRULIK M
Citation: E. Raymond et al., LONG-TERM FOLLOW-UP AFTER ADJUVANT CHEMOTHERAPY IN COMPLETELY RESECTED EARLY-STAGE OVARIAN-CARCINOMA, European journal of obstetrics, gynecology, and reproductive biology, 72(2), 1997, pp. 181-190
Citation: C. Louvet et A. Degramont, OXALIPLATIN - ROLE IN THE TREATMENT OF METASTATIC COLORECTAL-CANCER, La Revue de medecine interne, 18, 1997, pp. 368-371
Authors:
DEGRAMONT A
LOUVET C
ANDRE T
TOURNIGAND C
RAYMOND E
MOLITOR JL
KRULIK M
Citation: A. Degramont et al., LEUCOVORIN MODULATION OF FLUOROURACIL IN ADVANCED COLORECTAL-CANCER, La Revue de medecine interne, 18, 1997, pp. 372-378
Authors:
DEGRAMONT A
TOURNIGAND C
LOUVET C
ANDRE T
MOLITOR JL
RAYMOND E
MOREAU S
VIGNOUD J
LEBAIL N
KRULIK M
Citation: A. Degramont et al., OXALIPLATIN, LEUCOVORIN AND FLUOROURACIL IN PRETREATED PATIENTS WITH ADVANCED COLORECTAL-CANCER, La Revue de medecine interne, 18(10), 1997, pp. 769-775
Authors:
TOURNIGAND C
LOUVET C
DEGRAMONT A
LUCCHI E
SEITZ JF
MAL F
RAYMOND E
CADY J
CAROLA E
KRULIK M
Citation: C. Tournigand et al., BIMONTHLY HIGH-DOSE LEUCOVORIN AND 5-FLUOROURACIL 48-HOUR INFUSION WITH INTERFERON-ALPHA-2A IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, Cancer, 79(6), 1997, pp. 1094-1099
Authors:
BEERBLOCK K
RINALDI Y
ANDRE T
LOUVET C
RAYMOND E
TOURNIGAND C
CAROLA E
FAVRE R
DEGRAMONT A
KRULIK M
Citation: K. Beerblock et al., BIMONTHLY HIGH-DOSE LEUCOVORIN AND 5-FLUOROURACIL 48-HOUR CONTINUOUS-INFUSION IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, Cancer, 79(6), 1997, pp. 1100-1105
Authors:
MOREL P
MONCONDUIT M
JACOMY D
LENAIN P
GROSBOIS JM
FACON T
BATELI C
BAUTERS F
NAJMAN A
DEGRAMONT A
WATTEL E
Citation: P. Morel et al., A NEW SCORING SYSTEM IN WALDENSTROMS MACROGLOBULINEMIA (WM) - DESCRIPTION ON 232 PATIENTS (PTS) WITH VALIDATION ON 167 OTHER PTS, Blood, 90(10), 1997, pp. 1069-1069